Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 3
1949 3
1950 3
1951 11
1952 9
1953 6
1954 12
1955 7
1956 5
1957 14
1958 14
1959 17
1960 20
1961 19
1962 23
1963 46
1964 62
1965 70
1966 180
1967 215
1968 212
1969 198
1970 210
1971 188
1972 199
1973 231
1974 295
1975 369
1976 407
1977 604
1978 981
1979 1194
1980 15688
1981 33527
1982 34553
1983 35011
1984 36722
1985 37423
1986 38597
1987 39981
1988 41165
1989 42778
1990 44859
1991 46133
1992 46732
1993 47467
1994 48960
1995 49375
1996 49578
1997 49894
1998 50865
1999 52375
2000 54953
2001 56320
2002 59383
2003 63610
2004 71275
2005 77932
2006 86518
2007 93103
2008 103204
2009 110008
2010 119353
2011 128452
2012 133007
2013 138167
2014 139569
2015 140719
2016 136050
2017 131331
2018 133584
2019 135002
2020 147370
2021 154251
2022 141420
2023 140072
2024 114934
2025 5470

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,340,579 results

Results by year

Filters applied: . Clear all
Page 1
Fauci looks back-and ahead.
Cohen J. Cohen J. Science. 2022 Sep 9;377(6611):1137-1138. doi: 10.1126/science.ade7664. Epub 2022 Sep 8. Science. 2022. PMID: 36074850
Loved and hated, NIAID's chief plots life after government....
Loved and hated, NIAID's chief plots life after government....
Defining the risk of SARS-CoV-2 variants on immune protection.
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara VV, Ellebedy A, Fabrizio TP, Ferrari G, Fischer WM, Florence WC, Fouchier RAM, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MPG, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O'Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi PY, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turn… See abstract for full author list ➔ DeGrace MM, et al. Nature. 2022 May;605(7911):640-652. doi: 10.1038/s41586-022-04690-5. Epub 2022 Mar 31. Nature. 2022. PMID: 35361968 Free PMC article. Review.
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversit …
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immu …
Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.
Izzo AA. Izzo AA. Curr Opin Immunol. 2017 Aug;47:78-84. doi: 10.1016/j.coi.2017.07.008. Epub 2017 Jul 24. Curr Opin Immunol. 2017. PMID: 28750280 Free PMC article. Review.
Identifying pathways associated with killing this highly successful infectious agent has become critical to achieving the goal of reducing the global tuberculosis burden....
Identifying pathways associated with killing this highly successful infectious agent has become critical to achieving the goal of red …
NIH's ineffective funding policies.
Wahls WP. Wahls WP. Science. 2017 Jun 16;356(6343):1132-1133. doi: 10.1126/science.aan6504. Science. 2017. PMID: 28619908 No abstract available.
Development of a Universal Influenza Vaccine.
Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Diseases rece …
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our …
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Whitehead SS. Whitehead SS. Expert Rev Vaccines. 2016;15(4):509-17. doi: 10.1586/14760584.2016.1115727. Epub 2015 Dec 2. Expert Rev Vaccines. 2016. PMID: 26559731 Free PMC article. Review.
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus at vaccination, region and age. The National Institute of Allergy and Infectious Diseases has developed …
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus …
Ebola: public-private partnerships.
Reperant LA, van de Burgwal LH, Claassen E, Osterhaus AD. Reperant LA, et al. Science. 2014 Oct 24;346(6208):433-4. doi: 10.1126/science.346.6208.433-b. Science. 2014. PMID: 25342793 No abstract available.
New approaches for challenging therapeutic targets.
Sharma KR, Malik A, Roof RA, Boyce JP, Verma SK. Sharma KR, et al. Drug Discov Today. 2024 Apr;29(4):103942. doi: 10.1016/j.drudis.2024.103942. Epub 2024 Mar 5. Drug Discov Today. 2024. PMID: 38447929 Free article. Review.
The US National Institutes of Health hosted a workshop with the goal of identifying challenges and opportunities with alternative modalities for developing treatments across diseases associated with historically undruggable targets. This report highlig …
The US National Institutes of Health hosted a workshop with the goal of identifying challenges and opportunities with a …
From Lifespan to Healthspan.
Olshansky SJ. Olshansky SJ. JAMA. 2018 Oct 2;320(13):1323-1324. doi: 10.1001/jama.2018.12621. JAMA. 2018. PMID: 30242384 No abstract available.
Preface.
Gezmu M, Qin J. Gezmu M, et al. Stat Med. 2018 Jan 30;37(2):179-180. doi: 10.1002/sim.7551. Stat Med. 2018. PMID: 29250840 No abstract available.
3,340,579 results
You have reached the last available page of results. Please see the User Guide for more information.